Moderna Coronavirus Vaccine Shows Promise in Key Early Trial
A research associate works at the Moderna Therapeutics lab in Cambridge, Massachusetts. (Photographer: Adam Glanzman/Bloomberg)

Moderna Coronavirus Vaccine Shows Promise in Key Early Trial

Bookmark
(Bloomberg) -- Moderna Inc.’s Covid-19 vaccine produced antibodies to the coronavirus in all patients tested in an initial safety trial, federal researchers said, clearing an important milestone as...